Cure My Disease

Don't miss your cure!

 Log in / Sign up

30,000 blood samples could revolutionize rapid disease testing

NCT ID NCT07378514

Not yet recruiting Knowledge-focused Sponsor: LumiraDx UK Limited Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allows doctors to test patients right at their bedside. The goal is to make monitoring health conditions quicker and easier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could lead to faster, easier diagnostic tests that doctors can use right at the patient's bedside.

What could go wrong

This is a sample collection study, not a treatment trial. It is early-stage research focused on developing tests, so there is no direct benefit to participants and no guarantee the tests will work.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome diabetes mellitus heart disorder heart failure Hypercholesterolemia hyperlipidemia impaired renal function disease Infections infectious disease Inflammation inflammatory disease kidney disorder liver disorder prediabetes syndrome thrombotic disease type 1 diabetes mellitus 1 type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD CLOTS DIABETES HEART DISEASE HIGH CHOLESTEROL INFECTION AND INFLAMMATORY REACTION KIDNEY DISEASE LIVER DISEASE VITAMIN K ANTAGONIST

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••